These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30269787)

  • 1. Drosophila melanogaster as a model for the study of Malassezia pachydermatis infections.
    Merkel S; Heidrich D; Danilevicz CK; Scroferneker ML; Zanette RA
    Vet Microbiol; 2018 Oct; 224():31-33. PubMed ID: 30269787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
    Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
    Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of azoles, allylamines, and 8-hidroxiquinolines, alone and in combination, against Malassezia pachydermatis in vitro and in vivo.
    Merkel S; Pippi B; Reginatto P; Joaquim AR; Machado GRM; Heidrich D; Furasté ME; Silva JA; Konzen EJS; Scroferneker ML; Andrade SF; Fuentefria AM; Zanette RA
    J Mycol Med; 2024 Jun; 34(2):101475. PubMed ID: 38479291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phospholipase and proteinase production by Malassezia pachydermatis isolated in dogs with and without otitis].
    Ortiz G; Martín MC; Carrillo-Muñoz AJ; Payá MJ
    Rev Iberoam Micol; 2013; 30(4):235-8. PubMed ID: 23428748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
    Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
    Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin.
    Yurayart C; Nuchnoul N; Moolkum P; Jirasuksiri S; Niyomtham W; Chindamporn A; Kajiwara S; Prapasarakul N
    Med Mycol; 2013 Oct; 51(7):721-30. PubMed ID: 23547880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of Malassezia yeasts.
    Cafarchia C; Otranto D
    Parassitologia; 2008 Jun; 50(1-2):65-7. PubMed ID: 18693560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malassezia pachydermatis isolated from normal and diseased external ear canals in dogs: a comparative analysis.
    Girão MD; Prado MR; Brilhante RS; Cordeiro RA; Monteiro AJ; Sidrim JJ; Rocha MF
    Vet J; 2006 Nov; 172(3):544-8. PubMed ID: 16154787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malassezia pachydermatis with special reference to canine skin disease.
    Akerstedt J; Vollset I
    Br Vet J; 1996 May; 152(3):269-81. PubMed ID: 8762604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, body distribution, and population size of Malassezia species in healthy dogs and in dogs with localized cutaneous lesions.
    Cafarchia C; Gallo S; Romito D; Capelli G; Chermette R; Guillot J; Otranto D
    J Vet Diagn Invest; 2005 Jul; 17(4):316-22. PubMed ID: 16130988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial veterinary mycoses.
    Bond R
    Clin Dermatol; 2010 Mar; 28(2):226-36. PubMed ID: 20347667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between phospholipase production by Malassezia pachydermatis and skin lesions.
    Cafarchia C; Otranto D
    J Clin Microbiol; 2004 Oct; 42(10):4868-9. PubMed ID: 15472366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malassezia and its presumed association with skin diseases in dogs].
    Nagata M
    Med Mycol J; 2013; 54(1):45-7. PubMed ID: 23470954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activity of a killer peptide against Malassezia pachydermatis causing otitis in dogs.
    Cafarchia C; Immediato D; Paola GD; Magliani W; Ciociola T; Conti S; Otranto D; Polonelli L
    Med Mycol; 2014 May; 52(4):350-5. PubMed ID: 24625672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological and clinical aspects of the diseases caused by Malassezia species.
    Dorogi J
    Acta Microbiol Immunol Hung; 2002; 49(2-3):363-9. PubMed ID: 12109170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malassezia pachydermatis: a review.
    Guillot J; Bond R
    Med Mycol; 1999 Oct; 37(5):295-306. PubMed ID: 10520154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
    Lamaris GA; Chamilos G; Lewis RE; Kontoyiannis DP
    J Infect Dis; 2007 Dec; 196(12):1860-4. PubMed ID: 18190268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of yeasts and dermatophytes from healthy and diseased dogs.
    Prado MR; Brilhante RS; Cordeiro RA; Monteiro AJ; Sidrim JJ; Rocha MF
    J Vet Diagn Invest; 2008 Mar; 20(2):197-202. PubMed ID: 18319432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between genetic variability and virulence factors in clinical strains of Malassezia pachydermatis of animal origin.
    Buommino E; Nocera FP; Parisi A; Rizzo A; Donnarumma G; Mallardo K; Fiorito F; Baroni A; De Martino L
    New Microbiol; 2016 Jul; 39(3):216-223. PubMed ID: 27284984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
    Chamilos G; Lionakis MS; Lewis RE; Lopez-Ribot JL; Saville SP; Albert ND; Halder G; Kontoyiannis DP
    J Infect Dis; 2006 Apr; 193(7):1014-22. PubMed ID: 16518764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.